Has The Chairman Stopped Ordering Ink? Hewlett Packard Plummets After Hours On Major Downward Guidance Revision

Tyler Durden's picture

Looking at the price of HPQ after hours, one would think that the company was a biotech which just missed its Phase 3 trial. The rapidity with which it has lost $10 billion in market cap does not leave many other options... Of course, there is always the chance that Ben Bernanke may have just said no to future purchases of green ink, although we deem it highly unlikely. The real reason for the plunge in the stock was the company's earnings, which confirm that the new paradigm of economic growth, may be just slightly problematic. While the company missed on revenue, coming in at $32.3 Bn on expectations of $32.97 Bn, it is the forecast that left many stunned: HPQ now sees Q2 adjusted EPS $1.19-1.21 vs. Exp. $1.26, and full year revenue of $130-131.5bln vs. $132-133.5bln previously, and consensus of USD 133.1bln. So now in addition to plunging margins (Cisco) we are finally starting to see headline growth... And all the sellsiders continue to hike the 2011 EPS on what again?

Full outlook from the PR:

For the second quarter of fiscal 2011, HP estimates revenue of approximately $31.4 billion to $31.6 billion, GAAP diluted EPS in the range of $0.99 to $1.01, and non-GAAP diluted EPS in the range of $1.19 to $1.21.

Second quarter fiscal 2011 non-GAAP diluted EPS estimates exclude after-tax costs of approximately $0.20 per share, related primarily to the amortization of purchased intangibles, restructuring charges and acquisition-related charges.

HP expects full year fiscal 2011 revenue in the range $130 billion to $131.5 billion, GAAP diluted EPS in the range of $4.46 to $4.54, and non-GAAP diluted EPS in the range of $5.20 to $5.28.

Full year fiscal 2011 non-GAAP diluted EPS estimates exclude after-tax costs of approximately $0.74 per share, related primarily to the amortization of purchased intangibles, restructuring charges and acquisition-related charges.